Class II · Moderate riskTerminated Initiated May 6, 2019 (7 years ago)
MethylPREDNISolone Tablets, USP 4 mg per tablet, 21 Tablets dosepack, Rx Only, Made in…
Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.
Why it was recalled
CGMP Deviations: Cross Contamination with other products due to CGMP cleaning failure.
What was recalled
MethylPREDNISolone Tablets, USP 4 mg per tablet, 21 Tablets dosepack, Rx Only, Made in India Distributed by: Zydus Pharmaceuticals USA Inc. Pennington, NJ 08534. NDC 68382-916-34
Recalling firm
Zydus Pharmaceuticals USA Inc
NDC code
68382-916-34
Origin
NJ, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-1449-2019
What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.
Reason Labeling: Not Elsewhere Classified. Incorrect orientation of the blister foil applied to the blister cavities, which results in incorrect dosing…
Reason Labeling: Not Elsewhere Classified; A typographical error was observed in the NDC number on the preprinted Individual Folding Cartons (secondary…
Amneal Pharmaceuticals of New York, LLCNDC 70121-1574-01D-0756-2023